23andMe Holding Co. (NASDAQ:ME) Insider Kathy L. Hibbs Sells 38,551 Shares

23andMe Holding Co. (NASDAQ:ME - Get Free Report) insider Kathy L. Hibbs sold 38,551 shares of the business's stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $0.49, for a total value of $18,889.99. Following the transaction, the insider now directly owns 1,252,315 shares in the company, valued at approximately $613,634.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

23andMe Stock Down 3.1 %

NASDAQ:ME traded down $0.02 on Monday, reaching $0.49. The company's stock had a trading volume of 4,798,078 shares, compared to its average volume of 6,909,976. 23andMe Holding Co. has a 12-month low of $0.35 and a 12-month high of $2.21. The firm has a market cap of $234.99 million, a price-to-earnings ratio of -0.44 and a beta of 1.24. The stock has a 50 day moving average price of $0.49 and a 200 day moving average price of $0.70.

23andMe (NASDAQ:ME - Get Free Report) last posted its earnings results on Wednesday, February 7th. The company reported ($0.17) EPS for the quarter. 23andMe had a negative net margin of 210.48% and a negative return on equity of 52.99%. The business had revenue of $44.75 million during the quarter, compared to analysts' expectations of $56.30 million.

Institutional Investors Weigh In On 23andMe

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. China Universal Asset Management Co. Ltd. grew its stake in shares of 23andMe by 68.3% in the first quarter. China Universal Asset Management Co. Ltd. now owns 60,653 shares of the company's stock valued at $32,000 after buying an additional 24,604 shares in the last quarter. Raymond James & Associates grew its stake in shares of 23andMe by 113.5% in the third quarter. Raymond James & Associates now owns 36,173 shares of the company's stock valued at $35,000 after buying an additional 19,233 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of 23andMe in the third quarter valued at $37,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of 23andMe by 58.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 61,167 shares of the company's stock valued at $56,000 after buying an additional 22,460 shares in the last quarter. Finally, BKA Wealth Consulting Inc. acquired a new stake in shares of 23andMe in the fourth quarter valued at $126,000. Hedge funds and other institutional investors own 36.10% of the company's stock.

Analyst Ratings Changes

Separately, Citigroup decreased their target price on shares of 23andMe from $0.85 to $0.47 and set a "neutral" rating on the stock in a report on Tuesday, April 16th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.